Enlightenment Research’s Amgen AMGN Stock Holding History

Enlightenment Research’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,300	Closed	-$316K	–	94
2022 Q2	$316K	Buy	+1,300	New	+$319K	0.68%	57
2022 Q1	–	Sell	-2,200	Closed	-$495K	–	136
2021 Q4	$495K	Buy	+2,200	New	+$464K	0.7%	40
2021 Q2	–	Sell	-1,300	Closed	-$323K	–	133
2021 Q1	$323K	Buy	+1,300	New	+$310K	0.39%	73
2020 Q1	–	Sell	-2,300	Closed	-$554K	–	166
2019 Q4	$554K	Sell	2,300 -2,900	-56%	-$639K	2.59%	9
2019 Q3	$1.01M	Sell	5,200 -1,100	-17%	-$211K	2.23%	9
2019 Q2	$1.14M	Buy	+6,300	New	+$1.13M	0.58%	36

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Enlightenment Research's AMGN Position: Q3 2022 in Review

Enlightenment Research sold out of Amgen (AMGN) in Q3 2022, closing a stake of 1,300 shares — an estimated $316K sold.

Enlightenment Research first reported a position in AMGN in Q2 2019 and held it in 6 quarters. The position peaked at $1.14M in Q2 2019. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Enlightenment Research reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
Enlightenment Research sold 1,300 Amgen shares in Q3 2022, an estimated $316K.
Enlightenment Research first reported a position in Amgen in Q2 2019 and held it in 6 quarters.
Enlightenment Research's Amgen position peaked at $1.14M in Q2 2019.
2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Enlightenment Research's 13F filing for Q3 2022, filed 15 Nov 2022.